Aurinia Pharmaceuticals Inc.
AUPH
$15.14
$0.231.54%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.94% | 12.08% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.94% | 12.08% | |||
| Cost of Revenue | -41.54% | 1.61% | |||
| Gross Profit | 17.13% | 15.19% | |||
| SG&A Expenses | 0.63% | 27.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -89.95% | 108.76% | |||
| Total Operating Expenses | -12.22% | 27.44% | |||
| Operating Income | 47.27% | -13.61% | |||
| Income Before Tax | 44.26% | -9.01% | |||
| Income Tax Expenses | -36.08% | -36.02% | |||
| Earnings from Continuing Operations | 46.66% | -7.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 46.66% | -7.84% | |||
| EBIT | 47.27% | -13.61% | |||
| EBITDA | 38.10% | -11.24% | |||
| EPS Basic | 50.09% | -5.06% | |||
| Normalized Basic EPS | 46.90% | -11.34% | |||
| EPS Diluted | 44.20% | -0.31% | |||
| Normalized Diluted EPS | 45.16% | -10.44% | |||
| Average Basic Shares Outstanding | -2.27% | -2.91% | |||
| Average Diluted Shares Outstanding | -1.10% | -3.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||